세계의 팔꿈치관절 치환술 시장 : 시술 유형별, 최종사용자별, 지역별 - 성장, 동향, 예측(2018-2023년)

The damaged parts of the elbow are replaced with artificial elbow devices through a surgery which is known as elbow replacement. The growth is mainly driven by technological advancements and the growing burden of diseases such as osteoarthritis and rheumatoid arthritis. Elbow replacement can also be extended to cases, such as distal humerus fractures, distal humerus nonunions, and other elbow injuries. Rheumatoid Arthritis (RA) is a chronic systemic disease that affects the joints, connective tissues, muscle, tendons, and fibrous tissue. According to John Hopkins Research, the prevalence of rheumatoid arthritis is 1% to 2% globally, and the important joints involve wrist and elbow. Furthermore, the global increase in the number of geriatrics is likely to lead to consequences, like greater incidences of chronic and life-threatening diseases. Thus, the increasing disease burden of arthritis is expected to drive the elbow replacement market.

Key Market Trends

Total Elbow Replacement Segment is Expected to Show Better Growth in the Forecast Years

Based on the product, it is segmented into partial elbow replacement and total elbow replacement. In total elbow replacement surgery, the damaged parts of the humerus and ulna are replaced with artificial components. The segment is anticipated to grow at a significant rate due to an increase in the number of patients, advancing technologies, and rising prevalence of arthritis. As per the Centers for Disease Control and Prevention (CDC), in 2014, around 54 million U.S. adults had doctor-diagnosed arthritis. Arthritis is the leading cause of disability, stiffness, and swelling of the joints, which usually occurs in older people, resulting in a high demand for elbow replacement surgeries. Pertaining to these factors, the market is expected to grow over the forecast period.

North America Dominates the Elbow Replacement Market

The elbow replacement market dominates North America due to a sedentary lifestyle, the growing burden of rheumatoid arthritis and elbow injuries. According to World Health Organization, the prevalence of rheumatoid arthritis varies between 0.3% and 1% and is more common in women and in developed countries. According to a study published in 2016, in the United States, there is an increase in the number of total elbow arthroplasty procedures performed per year, which is expected to drive the market growth. Furthermore, advanced technology, rise in awareness among people toward extremities implants, and developed healthcare infrastructure are estimated to propel the elbow replacement market in the region.

Competitive Landscape

The global players into the elbow replacement market are Integra LifeSciences Corporation, Johnson & Johnson, Lima Corporate, Ottobock SE & Co. KGaA, Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Burden of Arthritis
  • 4.2.2 Technological Advancements
  • 4.2.3 Increased Awareness of the Procedure
• 4.3 Market Restraints
  • 4.3.1 Availability of Alternatives
  • 4.3.2 High Cost of the Procedure
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Product
  • 5.1.1 Partial Elbow Replacement
  • 5.1.2 Total Elbow Replacement
• 5.2 By End User
  • 5.2.1 Hospitals
  • 5.2.2 Orthopedic Centers
  • 5.2.3 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Integra LifeSciences Corporation
  • 6.1.2 Johnson & Johnson
  • 6.1.3 Lima Corporate
  • 6.1.4 Ottobock SE & Co. KGaA
  • 6.1.5 Stryker Corporation
  • 6.1.6 Wright Medical Group N.V.
  • 6.1.7 Zimmer Biomet

7 MARKET OPPORTUNITIES AND FUTURE TRENDS